About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT00994734

Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion

The primary aim of this study is to assess the acceptability of home-use mifepristone for termination of pregnancy among women who choose it and their providers. The investigators' secondary aims are ...

Lead sponsor: Gynuity Health Projects•4 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Gynuity Health Projects

Age

18 - 55 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Reproductive age women seeking abortion services.
•Eligible women will be in general good health and assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken.
•Participants must be eligible for medical abortion according to clinician and clinic standards.
•In the United States, women only 18 years and older will be eligible to participate, unless the study site obtains a waiver to include minors.

Related studies

Mechanisms and Factors Responsible for the Inhibition of Transposons During Fetal Gonad Development in Humans

NCT02171845 · Medical Termination of Pregnancy, Voluntary Termination of Pregnancy

Active Not Recruiting

Requests for Voluntary Termination and Medical Termination of Pregnancy for Maternal, Psychological or Social Reasons At the Women's Center ( La Maison Des Femmes) in Saint-Denis :

NCT06708208 · Pregnancy, Violence Against Women (VAW), and more

Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Randomized Against Valaciclovir - CYMEVALIII STEP1

NCT04732260 · Pregnant Women Undergoing TOP, TOP - Failed Attempted Termination of Pregnancy

COMPLETEDPhase 3

Use of Ultiva ® Associated With Xylocaine ® in the Procedures of Feticide

NCT02597699 · Termination of Pregnancy, Feticide

NAVIGATION ASSISTED CARE PROGRAM AND TERMINATION OF PREGNANCY

NCT05326854 · Termination of Pregnancy, Supportive Care, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 17, 2012Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment615

Start dateMay 2009

Last updatedApr 17, 2012

Condition

Termination of Pregnancy

Locations shown

Feminist Women's Health Center

Atlanta, Georgia

Institute for Family Health

New York, New York

Family Health Center, Montefiore Medical Center

The Bronx, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 17, 2012Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions